375 related articles for article (PubMed ID: 11413297)
21. Fusion promotion by a paramyxovirus hemagglutinin-neuraminidase protein: pH modulation of receptor avidity of binding sites I and II.
Palermo LM; Porotto M; Greengard O; Moscona A
J Virol; 2007 Sep; 81(17):9152-61. PubMed ID: 17567695
[TBL] [Abstract][Full Text] [Related]
22. Characterization of mutants of influenza A virus selected with the neuraminidase inhibitor 4-guanidino-Neu5Ac2en.
Gubareva LV; Bethell R; Hart GJ; Murti KG; Penn CR; Webster RG
J Virol; 1996 Mar; 70(3):1818-27. PubMed ID: 8627706
[TBL] [Abstract][Full Text] [Related]
23. The interaction of neuraminidase and hemagglutinin mutations in influenza virus in resistance to 4-guanidino-Neu5Ac2en.
Blick TJ; Sahasrabudhe A; McDonald M; Owens IJ; Morley PJ; Fenton RJ; McKimm-Breschkin JL
Virology; 1998 Jun; 246(1):95-103. PubMed ID: 9656997
[TBL] [Abstract][Full Text] [Related]
24. Catalytic and framework mutations in the neuraminidase active site of influenza viruses that are resistant to 4-guanidino-Neu5Ac2en.
Gubareva LV; Robinson MJ; Bethell RC; Webster RG
J Virol; 1997 May; 71(5):3385-90. PubMed ID: 9094607
[TBL] [Abstract][Full Text] [Related]
25. In vitro generation and characterisation of an influenza B variant with reduced sensitivity to neuraminidase inhibitors.
Cheam AL; Barr IG; Hampson AW; Mosse J; Hurt AC
Antiviral Res; 2004 Sep; 63(3):177-81. PubMed ID: 15451185
[TBL] [Abstract][Full Text] [Related]
26. Analysis of human parainfluenza virus 3 receptor binding variants: evidence for the use of a specific sialic acid-containing receptor.
Moscona A; Peluso RW
Microb Pathog; 1996 Mar; 20(3):179-84. PubMed ID: 8965678
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of replication of avian influenza viruses by the neuraminidase inhibitor 4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid.
Gubareva LV; Penn CR; Webster RG
Virology; 1995 Oct; 212(2):323-30. PubMed ID: 7571401
[TBL] [Abstract][Full Text] [Related]
28. Generation and characterization of variants of NWS/G70C influenza virus after in vitro passage in 4-amino-Neu5Ac2en and 4-guanidino-Neu5Ac2en.
McKimm-Breschkin JL; Blick TJ; Sahasrabudhe A; Tiong T; Marshall D; Hart GJ; Bethell RC; Penn CR
Antimicrob Agents Chemother; 1996 Jan; 40(1):40-6. PubMed ID: 8787876
[TBL] [Abstract][Full Text] [Related]
29. Hijacking the Fusion Complex of Human Parainfluenza Virus as an Antiviral Strategy.
Marcink TC; Yariv E; Rybkina K; Más V; Bovier FT; des Georges A; Greninger AL; Alabi CA; Porotto M; Ben-Tal N; Moscona A
mBio; 2020 Feb; 11(1):. PubMed ID: 32047132
[TBL] [Abstract][Full Text] [Related]
30. Role of neuraminidase in influenza virus-induced apoptosis.
Morris SJ; Price GE; Barnett JM; Hiscox SA; Smith H; Sweet C
J Gen Virol; 1999 Jan; 80 ( Pt 1)():137-146. PubMed ID: 9934696
[TBL] [Abstract][Full Text] [Related]
31. Amino acid change 335 E to K affects the sialic-acid-binding and neuraminidase activities of Urabe AM9 mumps virus hemagglutinin-neuraminidase glycoprotein.
Reyes-Leyva J; Baños R; Borraz-Argüello M; Santos-López G; Rosas N; Alvarado G; Herrera I; Vallejo V; Tapia-Ramírez J
Microbes Infect; 2007 Feb; 9(2):234-40. PubMed ID: 17223599
[TBL] [Abstract][Full Text] [Related]
32. Interaction between the hemagglutinin-neuraminidase and fusion glycoproteins of human parainfluenza virus type III regulates viral growth in vivo.
Xu R; Palmer SG; Porotto M; Palermo LM; Niewiesk S; Wilson IA; Moscona A
mBio; 2013 Oct; 4(5):e00803-13. PubMed ID: 24149514
[TBL] [Abstract][Full Text] [Related]
33. Characterization of human H1N1 influenza virus variants selected in vitro with zanamivir in the presence of sialic acid-containing molecules.
Giannecchini S; Campitelli L; Bandini G; Donatelli I; Azzi A
Virus Res; 2007 Nov; 129(2):241-5. PubMed ID: 17765996
[TBL] [Abstract][Full Text] [Related]
34. Fusion properties of cells infected with human parainfluenza virus type 3: receptor requirements for viral spread and virus-mediated membrane fusion.
Moscona A; Peluso RW
J Virol; 1992 Nov; 66(11):6280-7. PubMed ID: 1328668
[TBL] [Abstract][Full Text] [Related]
35. Inhibiting Human Parainfluenza Virus Infection by Preactivating the Cell Entry Mechanism.
Bottom-Tanzer SF; Rybkina K; Bell JN; Alabi CA; Mathieu C; Lu M; Biswas S; Vasquez M; Porotto M; Melero JA; Más V; Moscona A
mBio; 2019 Feb; 10(1):. PubMed ID: 30782664
[TBL] [Abstract][Full Text] [Related]
36. Mutations in a conserved residue in the influenza virus neuraminidase active site decreases sensitivity to Neu5Ac2en-derived inhibitors.
McKimm-Breschkin JL; Sahasrabudhe A; Blick TJ; McDonald M; Colman PM; Hart GJ; Bethell RC; Varghese JN
J Virol; 1998 Mar; 72(3):2456-62. PubMed ID: 9499107
[TBL] [Abstract][Full Text] [Related]
37. [Study on functions of N-carbohydrate chains in human parainfluenza virus type 3 hemagglutinin-neuraminidase protein].
Chu FL; Wen HL; Hou GH; Lin B; Zhang WQ; Song YY; Ren GJ; Sun CX; Li ZM; Wang ZY
Bing Du Xue Bao; 2013 Sep; 29(5):500-8. PubMed ID: 24386838
[TBL] [Abstract][Full Text] [Related]
38. Amino acid substitutions contributing to α2,6-sialic acid linkage binding specificity of human parainfluenza virus type 3 hemagglutinin-neuraminidase.
Fukushima K; Takahashi T; Ueyama H; Takaguchi M; Ito S; Oishi K; Minami A; Ishitsubo E; Tokiwa H; Takimoto T; Suzuki T
FEBS Lett; 2015 May; 589(11):1278-82. PubMed ID: 25871520
[TBL] [Abstract][Full Text] [Related]
39. Catalytic mechanism and novel receptor binding sites of human parainfluenza virus type 3 hemagglutinin-neuraminidase (hPIV3 HN).
Streltsov VA; Pilling P; Barrett S; McKimm-Breschkin JL
Antiviral Res; 2015 Nov; 123():216-23. PubMed ID: 26364554
[TBL] [Abstract][Full Text] [Related]
40. Structural Insights into Human Parainfluenza Virus 3 Hemagglutinin-Neuraminidase Using Unsaturated 3- N-Substituted Sialic Acids as Probes.
Pascolutti M; Dirr L; Guillon P; Van Den Bergh A; Ve T; Thomson RJ; von Itzstein M
ACS Chem Biol; 2018 Jun; 13(6):1544-1550. PubMed ID: 29693380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
